LSA
AGIO icon

Leonteq Securities AG’s Agios Pharmaceuticals AGIO Stock Holding History

Leonteq Securities AG’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-138
Closed -$3.06K – 1278
2022
Q2 		$3.06K Sell
138
-4
-3% -$90 ﹤0.01% 1178
2022
Q1 		$4.13K Hold
142
– – ﹤0.01% 1177
2021
Q4 		$4.67K Buy
+142
New +$5.72K ﹤0.01% 1189
2021
Q1 		– Sell
-1,191
Closed -$51.6K – 976
2020
Q4 		$51.6K Buy
+1,191
New +$47.1K ﹤0.01% 780

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Leonteq Securities AG's AGIO Position: Q3 2022 in Review

Leonteq Securities AG sold out of Agios Pharmaceuticals (AGIO) in Q3 2022, closing a stake of 138 shares — an estimated $3.06K sold.

Leonteq Securities AG first reported a position in AGIO in Q4 2020 and held it in 4 quarters. The position peaked at $51.6K in Q4 2020. 168 funds tracked by Wall St. Rank hold AGIO as of Q3 2022.

  • Leonteq Securities AG reported no remaining Agios Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Leonteq Securities AG sold 138 Agios Pharmaceuticals shares in Q3 2022, an estimated $3.06K.
  • Leonteq Securities AG first reported a position in Agios Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Leonteq Securities AG's Agios Pharmaceuticals position peaked at $51.6K in Q4 2020.
  • 168 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2022.

Based on Leonteq Securities AG's 13F filing for Q3 2022, filed 26 Mar 2026.